• Explore /
  • Poster
  • / A phase II trial of neoadjuvant nivolumab, docetaxel, and cisplatin therapy followed by surgery and radiation therapy for resectable high-grade salivary gland carcinoma.

A phase II trial of neoadjuvant nivolumab, docetaxel, and cisplatin therapy followed by surgery and radiation therapy for resectable high-grade salivary gland carcinoma.

Abstract Poster

Authors

Sehhoon Park

Sehhoon Park

Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

Sehhoon Park , Eun-hye Kim , Nayeon Choi , Junhun Cho , Hyun Ae Jung , Dongryul Oh , Se-Hoon Lee , Yong Chan Ahn , Han-Sin Jeong , Myung-Ju Ahn

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT05727410

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS6110)

DOI

10.1200/JCO.2023.41.16_suppl.TPS6110

Abstract #

TPS6110

Poster Bd #

97b

Abstract Disclosures

Similar Posters

First Author: Maliheh Mohamadpour

First Author: Katharine Andress Rowe Price

First Author: Tomoya Yokota

First Author: Rohit K. Jain